This is a summary of a recent NIH Workshop that provides an extensive review of HFpEF, which is considered a disease with the highest unmet need in cardiovascular disease. This provides insight into the disease and a forecast of future initiatives to address the need to better understand the disease and to explore promising therapies.
© Copyright 2025 Tenax Therapeutics. All Rights Reserved.
Site created by Top Shelf Design